Skip to content
Back to skills

Ata Pediatric Ppgl Approach

ASecurity

Investigates for pheochromocytoma and paraganglioma in children presenting with hypertension plus symptoms such as headache, excessive sweating, or palpitations. Notes the absence of pediatric reference values for endocrine tests and selects tumor resection as first-line treatment when triggered by pediatric hypertension with associated symptoms like headache or excessive sweating.

  • 12 stars
  • 0 votes
  • 0 copies
  • 6 views
  • Added September 9, 2026
documentationgorailstesting

Works with

  • cli

Security analysis

A100/100

Scanned September 9, 2026

npx -y skills add dromlakhani/MD2SKILL --skill ata-pediatric-ppgl-approach --agent claude-code

Installs into .claude/skills of the current project.

Are you the author of Ata Pediatric Ppgl Approach?

Add the live security badge to your README. It updates with every re-scan.

Security grade badge for Ata Pediatric Ppgl Approach
[![Security: A — Skills Directory](https://www.skillsdirectory.com/api/skills/dromlakhani-ata-pediatric-ppgl-approach/badge)](https://www.skillsdirectory.com/skills/dromlakhani-ata-pediatric-ppgl-approach)

More formats (shields.io, HTML) on the badges page. Keep it an A: scan every change in CI with Pro.

Download with Pro
SKILL.md
---
name: ata-pediatric-ppgl-approach
description: Investigates for pheochromocytoma and paraganglioma in children presenting with hypertension plus symptoms such as headache, excessive sweating, or palpitations. Notes the absence of pediatric reference values for endocrine tests and selects tumor resection as first-line treatment when triggered by pediatric hypertension with associated symptoms like headache or excessive sweating.
---

# Approach to pheochromocytoma and paraganglioma in children

## STEP 1 — Gather Information
Measure blood pressure to detect hypertension; document hallmark symptoms (headache, diaphoresis, palpitations), growth parameters, ADHD signs, and family history of PPGL or syndromic disease; obtain a creatinine‑corrected urine fractionated metanephrines sample for screening despite lack of pediatric cutoffs.

## STEP 2 — Rule In / Rule Out
If hypertension is present with any of the hallmark symptoms (headache, sweating, palpitations) → suspect PPGL and proceed to biochemical testing; if hypertension is absent or symptoms are unexplained → consider alternative diagnoses and rule out PPGL.

## STEP 3 — Classify or Stratify
Interpret endocrine test results using adult cutoffs with caution due to missing pediatric reference values; classify as biochemically positive if metanephrines exceed three times the adult upper limit of normal; then perform MRI (preferred in children to limit radiation) to locate adrenal or extra‑adrenal tumor; offer genetic testing when family history or syndromic features are present.

## STEP 4 — Decide
For biochemically positive and imaging‑confirmed PPGL, initiate preoperative α‑blockade (e.g., doxazosin) followed by definitive tumor resection (laparoscopic adrenalectomy when feasible) as first‑line treatment; if the tumor is unresectable, refer for multidisciplinary management per the metastatic algorithm.

## Clinical Guardrails / Mimics / Pitfalls
Do not rely solely on adult reference values without acknowledging possible false positives/negatives in children; avoid administering β‑blockers before adequate α‑blockade due to risk of hypertensive crisis; minimize radiation exposure by preferring MRI or ultrasound over CT when possible; remember that up to 70‑80% of pediatric PPGL cases harbor germline pathogenic variants, so early genetic counseling is essential.

## Concrete Clinical Example
A 12‑year‑old boy presents with intermittent frontal headaches, profuse sweating, and episodic palpitations; office BP is 152/94 mm Hg. Screening urine metanephrines (creatinine corrected) is 4 × the adult upper limit. Abdominal MRI reveals a 3 cm left adrenal mass. After 10 days of doxazosin titration, laparoscopic adrenalectomy is performed; pathology confirms adrenal pheochromocytoma. Post‑op BP normalizes and symptoms resolve.

**Source:** Japan Endocrine Society Clinical Practice Guideline for the Diagnosis and Management of Pheochromocytoma and Paraganglioma 2025, Japan Endocrine Society, 2025, doi:10.1507/endocrj.EJ25-0165

Attribution

Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.

Comments

Loading comments…

Newsletter

Get the weekly list of safe new skills, and the ones we pulled.